News & Press Releases
Filter by:
Mintz Advises Debticate in Acquisition by Automated Financial Systems
September 25, 2026
Mintz advised Debticate, Inc., an industry-leading provider of loan syndication and sales workflow software for financial institutions, in its acquisition by Automated Financial Systems, LLC (AFS), a portfolio company of OceanSound Partners.
Courtney Herndon Receives 2026 Mary K. Ryan Achievement in Pro Bono Award
September 25, 2026
Mintz attorney Courtney Herndon received the 2026 Mary K. Ryan Achievement in Pro Bono Award, presented by the Boston Bar Association at its Annual Meeting on September 24.
Rare USITC Fast-Track Proceeding Tests GG Technologies’ US Investment
September 24, 2026
Robert Vlasis was featured in an MLex article about the ITC’s recent use of its rarely invoked 100-day procedure in a patent dispute between GG Technologies and Apple. The article examines whether GG Technologies has made sufficient US investments to satisfy the domestic-industry requirement necessary to pursue relief under Section 337 of the Tariff Act.
Mintz Earns Leading Firm Recognition and Multiple Rankings in Chambers Canada 2027
September 24, 2026
Chambers Canada 2027 recognized Mintz as a Leading Firm in Canada 2027 and ranked the firm in Cannabis Law, Life Sciences, and Pensions & Benefits. The guide also recognized seven Toronto-based lawyers, including Toronto Office Managing Partner Mitch Frazer, Life Sciences Co-chair Cheryl Reicin, and Partner Eric Foster, who each earned Band 1 rankings in their respective categories.
Federal Contractor Fraud Defenses Broadened by DOJ Policy Shift
September 23, 2026
Karen Lovitch was quoted in a Bloomberg Law article discussing recent Department of Justice revisions to its False Claims Act enforcement policies, including changes related to the use of agency guidance documents in enforcement actions and its approach to dismissing certain whistleblower lawsuits.
Mintz Advises Lisata Therapeutics on Acquisition of Marea Therapeutics & $225M Concurrent Private Placement
September 22, 2026
Mintz advised Lisata Therapeutics, a clinical-stage pharmaceutical company, in its acquisition of Marea Therapeutics and the concurrent $225 million private placement financing.
